Novel Borrelia burgdorferi Sensu Lato Genospecies ID'd

This article originally appeared here.
Share this content:
Novel <i>Borrelia burgdorferi</i> Sensu Lato Genospecies ID'd
Novel Borrelia burgdorferi Sensu Lato Genospecies ID'd

WEDNESDAY, Feb. 10, 2016 (HealthDay News) -- A novel Borrelia burgdorferi sensu lato genospecies has been identified, which causes Lyme borreliosis, according to research published online Feb. 5 in The Lancet Infectious Diseases.

Bobbi S. Pritt, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues tested routine clinical diagnostic specimens with polymerase chain reaction (PCR) targeting the oppA1 gene of B. burgdorferi sensu lato.

The researchers found that six out of 100,545 specimens submitted for routine PCR between Jan. 1, 2003, and Sept. 30, 2014, yielded an atypical oppA1 PCR product. There were no atypical results detected before 2012. Of the patients with atypical PCR results, five presented with fever and one presented with knee pain and swelling, four had diffuse or focal rash, three had symptoms suggestive of neurological inclusion, and two were admitted to hospital. One patient had blood samples with motile spirochaetes and these were cultured from blood samples from two patients. The median oppA1 copy number was 180 times higher among the five blood specimens than in the 13 specimens that tested positive for B. burgdorferi sensu stricto. The spirochaete was identified as a novel B. burgdorferi sensu lato genospecies in multigene sequencing. Ticks collected at a probable patient exposure site had the same genospecies.

"Clinicians should be aware of this new B. burgdorferi sensu lato genospecies, its distinct clinical features, and the usefulness of oppA1 PCR for diagnosis," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »